Insights

Expansion into combo vaccines Novavax is actively developing next-generation flu-COVID-19 combination shots in partnership with companies like Sanofi, creating potential sales opportunities in the expanding field of combination vaccines.

Strategic partnerships for growth Through significant deals like the $1.2B agreement with Sanofi for co-commercializing vaccines and developing combo shots, Novavax is positioning itself for sales growth through strategic partnerships and collaborations.

Financial backing for R&D With recent equity investments totaling $1.2B and licensing agreements to support R&D efforts, Novavax has secured substantial financial backing, indicating potential sales growth in novel vaccine development and production.

Vaccine portfolio expansion Novavax's focus on developing life-saving vaccines to combat infectious diseases, along with expanding its pipeline with JN.1 booster and COVID-flu combo vaccines, presents sales opportunities in a diversified vaccine portfolio.

Competitive edge in adjuvanted vaccines Possessing the sole license to its adjuvanted COVID-19 vaccine and developing an Influenza Combination vaccine candidate reinforces Novavax's competitive edge, setting the stage for sales growth in the vaccine market.

Novavax Tech Stack

Novavax uses 8 technology products and services including GitHub, MongoDB, Microsoft PowerPoint, and more. Explore Novavax's tech stack below.

  • GitHub
    Communication And Collaboration
  • MongoDB
    Database
  • Microsoft PowerPoint
    Editors
  • Modernizr
    Javascript Libraries
  • Amazon Web Services
    Platform As A Service
  • SAP Predictive Analytics
    Predictive Analytics
  • Google Tag Manager
    Tag Management
  • Adobe Tag Manager
    Tag Management

Media & News

Novavax's Email Address Formats

Novavax uses at least 1 format(s):
Novavax Email FormatsExamplePercentage
lastfir@novavax.comDoeJoh@novavax.com
33%
lf@novavax.comDJ@novavax.com
23%
lfirst@novavax.comDJohn@novavax.com
22%
f.last@novavax.comJ.Doe@novavax.com
22%

Frequently Asked Questions

Where is Novavax's headquarters located?

Minus sign iconPlus sign icon
Novavax's main headquarters is located at 700 Quince Orchard Rd Gaithersburg, Maryland 20878 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Novavax's phone number?

Minus sign iconPlus sign icon
You can contact Novavax's main corporate office by phone at +1-240-268-2000. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Novavax's stock symbol?

Minus sign iconPlus sign icon
Novavax is a publicly traded company; the company's stock symbol is NVAX.

What is Novavax's official website and social media links?

Minus sign iconPlus sign icon
Novavax's official website is novavax.com and has social profiles on LinkedIn.

How much revenue does Novavax generate?

Minus sign iconPlus sign icon
As of May 2024, Novavax's annual revenue reached $750M.

What is Novavax's NAICS code?

Minus sign iconPlus sign icon
Novavax's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novavax have currently?

Minus sign iconPlus sign icon
As of May 2024, Novavax has approximately 1.2K employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: R. H.Chief Executive Officer: P. L.Chief Operations Officer: R. C.. Explore Novavax's employee directory with LeadIQ.

What industry does Novavax belong to?

Minus sign iconPlus sign icon
Novavax operates in the Pharmaceutical Manufacturing industry.

What technology does Novavax use?

Minus sign iconPlus sign icon
Novavax's tech stack includes GitHubMongoDBMicrosoft PowerPointModernizrAmazon Web ServicesSAP Predictive AnalyticsGoogle Tag ManagerAdobe Tag Manager.

What is Novavax's email format?

Minus sign iconPlus sign icon
Novavax's email format typically follows the pattern of . Find more Novavax email formats with LeadIQ.

How much funding has Novavax raised to date?

Minus sign iconPlus sign icon
As of May 2024, Novavax has raised $85M in funding. The last funding round occurred on Aug 08, 2023.

When was Novavax founded?

Minus sign iconPlus sign icon
Novavax was founded in 1987.
Novavax

Novavax

Pharmaceutical ManufacturingMaryland, United States1001-5000 Employees

We’re making a difference in the health of people around the world by producing next generation vaccines that are accessible to more people. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our hopes. We do this work for the greater health of people everywhere. It’s more than our job. It’s our passion.

Our Novavax Social Community Guidelines: https://www.novavax.com/social-media-community-guidelines

Section iconCompany Overview

Headquarters
700 Quince Orchard Rd Gaithersburg, Maryland 20878 US
Phone number
+1-240-268-2000
Stock Symbol
NVAX
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1987
Employees
1001-5000

Section iconFunding & Financials

  • $85M

    Novavax has raised a total of $85M of funding over 10 rounds. Their latest funding round was raised on Aug 08, 2023.

  • $100M$1B

    Novavax's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $85M

    Novavax has raised a total of $85M of funding over 10 rounds. Their latest funding round was raised on Aug 08, 2023.

  • $100M$1B

    Novavax's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.